Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.[ Read More ]
The intrinsic value of one HSCS stock under the base case scenario is HIDDEN Compared to the current market price of 2.59 USD, Heart Test Laboratories, Inc. is HIDDEN
Current Assets | 7.35 M |
Cash & Short-Term Investments | 5.81 M |
Receivables | 0 |
Other Current Assets | 1.55 M |
Non-Current Assets | 2.15 M |
Long-Term Investments | 0 |
PP&E | 560 K |
Other Non-Current Assets | 1.59 M |
Current Liabilities | 1.75 M |
Accounts Payable | 448 K |
Short-Term Debt | 602 K |
Other Current Liabilities | 701 K |
Non-Current Liabilities | 434 K |
Long-Term Debt | 434 K |
Other Non-Current Liabilities | 0 |
Revenue | 18.6 K |
Cost Of Revenue | 6.08 K |
Gross Profit | 12.5 K |
Operating Expenses | 6.32 M |
Operating Income | -6.31 M |
Other Expenses | 299 K |
Net Income | -6.61 M |
Net Income | -6.61 M |
Depreciation & Amortization | 95.1 K |
Capital Expenditures | -125 K |
Stock-Based Compensation | 405 K |
Change in Working Capital | -504 K |
Others | 171 K |
Free Cash Flow | -6.2 M |
Date | Value | Insider | Amount | Avg Price |
---|